Annual ROE
-37.76%
+10.70%+22.08%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual return on equity is -37.76%, with the most recent change of +10.70% (+22.08%) on December 31, 2023.
- During the last 3 years, FATE annual ROE has risen by +17.35% (+31.48%).
- FATE annual ROE is now -240.06% below its all-time high of 26.96%, reached on December 31, 2012.
Performance
FATE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-45.55%
-2.31%-5.34%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly return on equity is -45.55%, with the most recent change of -2.31% (-5.34%) on September 30, 2024.
- Over the past year, FATE quarterly ROE has dropped by -8.23% (-22.05%).
- FATE quarterly ROE is now -111.41% below its all-time high of 399.15%, reached on December 31, 2013.
Performance
FATE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
FATE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.1% | -22.1% |
| 3 y3 years | +31.5% | -4.5% |
| 5 y5 years | +32.6% | +18.2% |
FATE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.1% | -43.2% | +6.4% |
| 5 y | 5-year | at high | +31.5% | -43.2% | +18.2% |
| alltime | all time | -240.1% | +58.2% | -111.4% | +86.2% |
Fate Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -45.55%(+5.3%) |
| Jun 2024 | - | -43.24%(-3.9%) |
| Mar 2024 | - | -44.98%(+21.3%) |
| Dec 2023 | -37.76%(-22.1%) | -37.07%(-0.7%) |
| Sep 2023 | - | -37.32%(-11.9%) |
| Jun 2023 | - | -42.35%(-2.9%) |
| Mar 2023 | - | -43.61%(-10.4%) |
| Dec 2022 | -48.46%(+21.5%) | -48.66%(+4.0%) |
| Sep 2022 | - | -46.80%(+24.5%) |
| Jun 2022 | - | -37.59%(+15.8%) |
| Mar 2022 | - | -32.46%(+2.1%) |
| Dec 2021 | -39.90%(-27.6%) | -31.80%(-0.3%) |
| Sep 2021 | - | -31.91%(-15.0%) |
| Jun 2021 | - | -37.52%(-7.0%) |
| Mar 2021 | - | -40.34%(-18.7%) |
| Dec 2020 | -55.11%(+13.8%) | -49.63%(+8.9%) |
| Sep 2020 | - | -45.56%(+4.3%) |
| Jun 2020 | - | -43.68%(-21.5%) |
| Mar 2020 | - | -55.66%(+7.4%) |
| Dec 2019 | -48.44%(-13.6%) | -51.84%(+5.7%) |
| Sep 2019 | - | -49.03%(-15.0%) |
| Jun 2019 | - | -57.65%(-4.7%) |
| Mar 2019 | - | -60.48%(-4.0%) |
| Dec 2018 | -56.05% | -63.02%(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -76.23%(-21.1%) |
| Jun 2018 | - | -96.57%(+26.3%) |
| Mar 2018 | - | -76.48%(+12.2%) |
| Dec 2017 | -57.14%(-5.1%) | -68.14%(-6.5%) |
| Sep 2017 | - | -72.90%(-3.7%) |
| Jun 2017 | - | -75.70%(-7.0%) |
| Mar 2017 | - | -81.42%(-7.3%) |
| Dec 2016 | -60.19%(-33.4%) | -87.86%(-13.5%) |
| Sep 2016 | - | -101.59%(+22.7%) |
| Jun 2016 | - | -82.77%(+1.0%) |
| Mar 2016 | - | -81.92%(+0.4%) |
| Dec 2015 | -90.37%(+38.2%) | -81.63%(+1.7%) |
| Sep 2015 | - | -80.28%(-2.0%) |
| Jun 2015 | - | -81.94%(+2.8%) |
| Mar 2015 | - | -79.72%(+21.7%) |
| Dec 2014 | -65.37%(+59.1%) | -65.50%(-46.9%) |
| Sep 2014 | - | -123.44%(-31.4%) |
| Jun 2014 | - | -179.85%(-45.5%) |
| Mar 2014 | - | -330.15%(-182.7%) |
| Dec 2013 | -41.09%(-252.4%) | 399.15%(+722.5%) |
| Sep 2013 | - | 48.53%(-25.9%) |
| Jun 2013 | - | 65.50%(+192.8%) |
| Mar 2013 | - | 22.37%(+42.9%) |
| Dec 2012 | 26.96%(+1.8%) | 15.65% |
| Dec 2011 | 26.49% | - |
FAQ
- What is Fate Therapeutics annual return on equity?
- What is the all time high annual ROE for Fate Therapeutics?
- What is Fate Therapeutics annual ROE year-on-year change?
- What is Fate Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Fate Therapeutics?
- What is Fate Therapeutics quarterly ROE year-on-year change?
What is Fate Therapeutics annual return on equity?
The current annual ROE of FATE is -37.76%
What is the all time high annual ROE for Fate Therapeutics?
Fate Therapeutics all-time high annual return on equity is 26.96%
What is Fate Therapeutics annual ROE year-on-year change?
Over the past year, FATE annual return on equity has changed by +10.70% (+22.08%)
What is Fate Therapeutics quarterly return on equity?
The current quarterly ROE of FATE is -45.55%
What is the all time high quarterly ROE for Fate Therapeutics?
Fate Therapeutics all-time high quarterly return on equity is 399.15%
What is Fate Therapeutics quarterly ROE year-on-year change?
Over the past year, FATE quarterly return on equity has changed by -8.23% (-22.05%)